LSL Pharma Group is dedicated to enhancing public health through a diverse range of pharmaceutical and natural health products. The company operates three manufacturing facilities, including Steri-Med Pharma, which specializes in sterile pharmaceutical products such as ointments suitable for both humans and pets. Additionally, Laboratoire LSL has over 20 years of experience in the development and production of natural health products, while Virage Santé, founded in 1994, not only manufactures and distributes its own natural health brands but also serves as a Contract Development and Manufacturing Organization (CDMO). This strategic focus on manufacturing capabilities supports LSL Pharma Group's growth objectives and commitment to quality.

The company emphasizes innovation and expertise in its operations, which are crucial for maintaining high standards in product development and manufacturing. By continuously evolving its facilities and processes, LSL Pharma Group aims to meet the increasing demands of the health market while ensuring the safety and efficacy of its products. The integration of CDMO services further enhances its ability to collaborate with other companies, thereby expanding its reach and impact in the health sector.

Canada

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing, and distribution of pharmaceutical products. The company has completed the acquisition of Virage Santé and has entered into an exclusive distribution agreement with Fera Pharmaceuticals to alleviate drug shortage in U.S. hospitals. LSL Pharma Group Inc. is listed on the TSX Venture Exchange under the ticker symbol LSL.V.

LSL Pharma Group

Company Details